NCT05306379View on ClinicalTrials.gov

Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

April 5, 2022

Study Completion Date

April 5, 2022

Conditions
Drug-drug Interaction
Interventions
DRUG

Simvastatin

Oral dose 40 mg

DRUG

Voclosporin

Oral dose 23.7 mg twice daily

Trial Locations (1)

75247

Labcorp Clinical Research Unit, Dallas

Sponsors
All Listed Sponsors
lead

Aurinia Pharmaceuticals Inc.

INDUSTRY